Ana Isabel Rojo Sanchís-rekin lankidetzan egindako argitalpenak (2)

2011

  1. Pharmacological targeting of the transcription factor NRf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism

    Antioxidants and Redox Signaling, Vol. 14, Núm. 12, pp. 2347-2360

2006

  1. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice

    European Journal of Neuroscience, Vol. 24, Núm. 7, pp. 1874-1884